JLABS @ LabCentral QuickFire Challenge
Challenge ended
Residency at JLABS
Consumer Health
Digital Health
Winners
Cyteir Therapeutics is developing new drugs to treat cancer and chronic autoimmunity.
Riparian Pharmaceuticals is an early-stage biotechnology company employing innovative models of vascular pathophysiology to discover novel therapeutics.
XTuit Pharmaceuticals is pursuing novel approaches to improving cancer therapy by targeting the tumor microenvironment.
The Challenge
In honor of the upcoming Grand Opening of JLABS @ LabCentral, Johnson & Johnson Innovation has launched a QuickFire Challenge to award new game-changing early-stage innovation companies with the use of a bench, workstation and access to the JLABS @ LabCentral community for one year.